CytomX Therapeutics Inc — Cash Flow (NASDAQ:CTMX) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities 5.26 M119.03 M110.79 M56.03 M86.23 M 72.25 M Cash from investing activities 18.72 M22.49 M98.26 M150.67 M99.7 M 60.46 M Cash from financing activities 16.89 M110.21 M648 K30.23 M7.52 M 96.05 M Free cash flow 2.95 M117.42 M109.05 M55.2 M85.92 M 72.15 M

新闻

NovoCure (NVCR) Reports Q4 Loss, Beats Revenue Estimates

AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Tops Revenue Estimates

古根海姆峰会上的CytomX：前景看好的结直肠癌治疗路径

CytomX at Guggenheim Summit: Promising CRC Treatment Path

Qiagen (QGEN) Meets Q4 Earnings Estimates

CytomX Therapeutics stock hits 52-week high at 6.16 USD

Regenxbio (RGNX) Soars 5.4%: Is Further Upside Left in the Stock?

Qiagen (QGEN) Soars 16.6%: Is Further Upside Left in the Stock?

Piper Sandler raises CytomX Therapeutics stock price target to $10 on cancer drug data

CytomX Stock Rises 31% in a Month: Here's What You Should Know

CytomX Therapeutics, Inc. (CTMX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

CytomX Therapeutics: EpCAM Is Back, Now Prove It Holds (Rating Downgrade) (NASDAQ:CTMX)